Breast screening: The facts - Or maybe not

BMJ (Online)

Volumn 338, Issue 7692, 2009, Pages 446-448

  Gøtzsche, Peter C ^a   Hartling, Ole J ^b   Nielsen, Margrethe ^a   Brodersen, John ^c   Jørgensen, Karsten Juhl ^a  

^a Rigshospitalet   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; DECISION MAKING; INFORMED CONSENT; LABORATORY DIAGNOSIS; MAMMOGRAPHY; MASTECTOMY; MEDICAL INFORMATION; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SHORT SURVEY;

EID: 61849137123     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (19)

1. Jørgensen KJ, Gøtzsche PC. Content of invitations to publicly funded screening mammography. BMJ 2006;332:538-41.
2. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006;(4):CD001877.
3. Vainio H, Bianchini F. IARC handbooks of cancer prevention. Vol 7: breast cancer screening. Lyon: IARC Press, 2002.
4. Raffle A, Gray M. Screening: evidence and practice. Oxford: Oxford University Press, 2007.
5. Department of Health, NHS Cancer Screening Programmes. Breast screening: the facts. 2006. www.cancerscreening.nhs.uk/breastscreen/ publications/ia-02.html..
6. General Medical Council. Consent: patients and doctors making decisions together. London: GMC, 2008. www.gmc-uk.org/guidance/ethical- guidance/consent-guidance/index.asp.
7. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, eds. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities, 2006.
8. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338:1089-96.
9. Hofvind S, Thoresen S, Tretli S. The cumulative risk of a false-positive recall in the Norwegian breast cancer screening program. Cancer 2004;101:1501-7.
10. Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value in Health 2007;10:294-304.
11. Brodersen J. Measuring psychosocial consequences of false-positive screening results - breast cancer as an example. Department of General Practice, University of Copenhagen. 2006. http://cms.ku.dk/sund-sites/ifsv- sites/ifsv-inst/ominstituttet/afdelinger/almen-medicin/medarbejdere/ publicationdetail/?id=1109837.
12. Barton MB, Moore S, Polk S, Shtatland E, Elmore JG, Fletcher SW. Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J Gen Intern Med 2001;16:150-6.
13. Zahl P-H, Strand BH, Mahlen J. Breast cancer incidence in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004;328:921-4.
14. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly 14 organised mammography screening programmes: systematic review of incidence trends. BMJ (in press).
15. Darby S, McGale P, Taylor C, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries. Lancet Oncol 2005;6:557-65.
16. Department of Health, NHS Cancer Screening Programmes. Screening for breast cancer in England: past and future. 2006. www.cancerscreening.nhs.uk/ breastscreen/publications/nhsbsp61.html.
17. Domenighetti G, D'Avanzo B, Egger M, Berrino F, Perneger T, Mosconi P, et al. Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol 2003;32:816-21.
18. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA 2004;291:71-8.
19. Thornton H, Edwards A, Baum M. Women need better information about routine mammography. BMJ 2003;327:101-3.